News Press Releases Genenta to Present at Upcoming Scientific and Investor Conferences Sep 06, 2023 Genenta Announces Ongoing Clinical Trial Progress and Proposed Expansion in Solid Tumor Treatments Jul 28, 2023 The European Commission Grants Orphan Drug Designation to Temferon™ for Treatment of Glioma Jun 29, 2023 Learn More Upcoming Events EDGE 2023 Innovation Impact Technology Dec 5, 2023 Learn More Learn More Corporate Information Genenta Corporate Deck October 2023 Aug 16, 2023 Call of the ordinary and extraordinary shareholders’ meeting Jun 09, 2023 Financial Metrics Price Change Day High Day Low Volume Nov 30, 2023 2:08 AM EST Stock Chart Data Provided by Refinitiv. Minimum 15 minutes delayed. Learn More
Genenta Announces Ongoing Clinical Trial Progress and Proposed Expansion in Solid Tumor Treatments Jul 28, 2023
The European Commission Grants Orphan Drug Designation to Temferon™ for Treatment of Glioma Jun 29, 2023